Page 5 - Celularity News Today

Veteran pharmaceutical executive brings more than 15 years of proven oncology and immunology experience...

FLORHAM PARK, N.J., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing...

Celularity (NASDAQ:CELU – Get Rating) and Kezar Life Sciences (NASDAQ:KZR – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Valuation and Earnings This table compares Celularity and Kezar […]

Pharmaceutical and Biotech Industry Veteran Brings Significant Strategic Development and Commercialization Expertise Launching New Cellular Therapies...

OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.30 A.M. ET).In the GreenEsports Technologies, Inc. (EBET) is up over 33% at $3.68 Affirm

Equities research analysts expect Celularity Inc. (NASDAQ:CELU – Get Rating) to post earnings of ($0.23) per share for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Celularity’s earnings, with the highest EPS estimate coming in at ($0.11) and the lowest estimate coming in at ($0.29). The company is scheduled to […]

Zacks Investment Research lowered shares of Celularity (NASDAQ:CELU – Get Rating) from a buy rating to a hold rating in a report published on Monday, Zacks.com reports. According to Zacks, “Celularity Inc. is a clinical stage biotechnology company. It involved in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified […]

Celularity Inc. (NASDAQ:CELU – Get Rating)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $8.88, but opened at $8.62. Celularity shares last traded at $8.69, with a volume of 234 shares changing hands. A number of research analysts recently commented on CELU shares. Zacks Investment Research downgraded […]

Celularity Inc (NASDAQ:CELU – Get Rating)’s stock price traded down 13.7% during trading on Monday . The company traded as low as $7.60 and last traded at $7.77. 8,943 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 206,427 shares. The stock had previously closed at $9.00. A […]

Celularity Inc (NASDAQ:CELU – Get Rating) was the target of some unusual options trading on Wednesday. Investors purchased 1,734 call options on the stock. This represents an increase of approximately 502% compared to the typical volume of 288 call options. Several hedge funds and other institutional investors have recently modified their holdings of the company. […]